A method for monitoring response to therapy and recurrence of breast cancer
    8.
    发明公开
    A method for monitoring response to therapy and recurrence of breast cancer 审中-公开
    用于监测对治疗的反应和乳腺癌的复发的方法

    公开(公告)号:EP2905619A1

    公开(公告)日:2015-08-12

    申请号:EP14154030.2

    申请日:2014-02-05

    IPC分类号: G01N33/574

    CPC分类号: G01N33/57415 G01N33/57488

    摘要: A method of monitoring a breast cancer patient's response to treatment, or of detecting recurrence of breast cancer, the method comprising a step of assaying a plurality of samples obtained from the patient over a period of time for expression levels of a plurality of biomarkers including Cancer Antigen 15-3 (CA 15-3) and one of either Glutamate or 12-Hydroxyeicosatetraenoic acid (12-HETE), and detecting a change in expression levels of CA 15-3 and one (or both) of either Glutamate or 12-HETE over the time period, wherein detection of a decreased expression levels of CA 15-3 and one of either Glutamate or 12-HETE over the time period is indicative of a response to therapy and wherein detection of increased or stable expression levels of CA 15-3 and one of either Glutamate or 12-HETE over the time period is indicative of a non-response to breast cancer therapy.

    摘要翻译: 监测乳腺癌患者的治疗,或检测乳腺癌复发的应答的方法,该方法包括:在对生物标记物,包括癌症的多个表达水平在一段时间内测定从患者获得的样品中的多个步骤 抗原15-3(CA 15-3),要么谷氨酸或12-羟二十酸(12-HETE)中的一个,和检测在谷氨酸单个或CA 15-3和一个(或两个)的表达水平的变化-12- HETE在TIMEPERIOD,CA 15-3的降低的表达水平的worin检测和一个无论是谷氨酸或12-HETE在TIMEPERIOD的指示对治疗和CA 15的worin增加的或稳定的表达水平的检测的响应的 -3和要么谷氨酸或12-HETE在TIMEPERIOD之一是指示非响应于乳腺癌的治疗。